1. Home
  2. DERM vs PIM Comparison

DERM vs PIM Comparison

Compare DERM & PIM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

DERM

Journey Medical Corporation

HOLD

Current Price

$5.07

Market Cap

135.3M

Sector

Health Care

ML Signal

HOLD

Logo Putnam Master Intermediate Income Trust

PIM

Putnam Master Intermediate Income Trust

HOLD

Current Price

$3.30

Market Cap

159.5M

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
DERM
PIM
Founded
2014
1988
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Finance Companies
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
135.3M
159.5M
IPO Year
2021
N/A

Fundamental Metrics

Financial Performance
Metric
DERM
PIM
Price
$5.07
$3.30
Analyst Decision
Strong Buy
Analyst Count
3
0
Target Price
$12.67
N/A
AVG Volume (30 Days)
154.6K
66.2K
Earning Date
05-13-2026
01-01-0001
Dividend Yield
N/A
8.28%
EPS Growth
34.72
N/A
EPS
N/A
0.05
Revenue
$61,858,000.00
N/A
Revenue This Year
$39.72
N/A
Revenue Next Year
$63.24
N/A
P/E Ratio
N/A
$64.00
Revenue Growth
10.20
N/A
52 Week Low
$4.31
$3.14
52 Week High
$9.56
$3.50

Technical Indicators

Market Signals
Indicator
DERM
PIM
Relative Strength Index (RSI) 41.85 59.39
Support Level $4.85 $3.29
Resistance Level $5.50 $3.36
Average True Range (ATR) 0.27 0.04
MACD 0.07 0.00
Stochastic Oscillator 41.82 89.58

Price Performance

Historical Comparison
DERM
PIM

About DERM Journey Medical Corporation

Journey Medical Corp is a commercial-stage pharmaceutical company that focuses on the selling and marketing of U.S. Food and Drug Administration (FDA) approved prescription pharmaceutical products for the treatment of dermatological conditions. Its current product portfolio includes FDA-approved prescription drugs for dermatological conditions that are marketed in the U.S. The company views its operations and manages its business in one segment, which reflects products for the treatment of dermatological conditions. The dermatological segment derives revenues from the sale of branded and authorized general prescription products that treat certain dermatological conditions.

About PIM Putnam Master Intermediate Income Trust

Putnam Master Intermediate Income Trust is a closed-end fund. Its investment objective is to provide high current income and relative stability of net asset value. The fund pursues its goal by investing in U.S. high-grade, high-yield, and international fixed-income securities with limited maturities. The fund's portfolio includes the United States Government and agency mortgage obligations; mortgage-backed securities; corporate bonds and notes, and foreign government and agency bonds and notes.

Share on Social Networks: